Press Releases

TriNet Insights Presents: Navigating Uncertainties to Reach the Next Levels for Midsize Biotech Companies

WHO: Craig Shimasaki, Ph.D., MBA is president & CEO of Moleculera Labs, an autoimmune neurobiology company. He is a scientist and serial entrepreneur with over 32 years of biotechnology industry experience. In addition to co-founding three companies, he is the author and editor of two books – “The Business of Bioscience: What Goes into Making a Biotechnology Product” and “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies.” He is an adjunct professor at the University of Oklahoma, Price School of Business, where he teaches biotechnology entrepreneurship.

WHAT:  Established biotech companies deal with challenges that are unique and different from those they confronted when they were start-ups.

In this free event, Dr. Shimasaki will share his experiences as an entrepreneur in the biotech industry. He will give tips for how to avoid some of the most daunting challenges biotech companies face, such as:

  • How to manage cash consumption for product development.
  • Dealing with the uncertainty inherent in preclinical and clinical testing outcomes.
  • Moving beyond just generating revenue to turning a profit.
  • Avoiding unexpected pitfalls.
  • Preventing catastrophes while preparing for uncertainty.

Complimentary lunch will be served.

WHEN: Wednesday, Aug. 17, 2016
11:30 a.m. – 1 p.m. PT

WHEREgreenACRE Campus Pointe: Brian Malarkey’s eatery
10300 Campus Point Dr.
San Diego, CA 92121

REGISTER: RSVP here; space is limited.

CONTACT:
Jock Breitwieser
TriNet
Jock.Breitwieser@trinet.com  
510.875.7250

Latest Press Releases

TriNet Announces Pricing of a Private Offering of $500 Million of Senior Notes due 2029

February 23, 2021

DUBLIN, Calif., Feb. 23, 2021 /PRNewswire/ -- TriNet Group, Inc. ("TriNet" or the "Company") (NYSE: TNET), a leading provider of comprehensive human resources solutions for small and medium-size businesses, announced today that it has priced $500 million in aggregate principal amount of its 3.5% senior notes due 2029 (the "notes") in a private offering (the "offering") that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act").

TriNet Announces Proposed Private Offering of $500 Million of Senior Notes due 2029

February 22, 2021

DUBLIN, Calif., Feb. 22, 2021 /PRNewswire/ -- TriNet Group, Inc. ("TriNet" or the "Company") (NYSE: TNET), a leading provider of comprehensive human resources solutions for small and medium-size businesses, announced today that it intends to offer, subject to market and other conditions, $500 million in aggregate principal amount of its senior notes due 2029 (the "notes") in a private offering (the "offering") that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act").

TriNet Announces Fourth Quarter and Fiscal Year 2020 Results

February 16, 2021

DUBLIN, Calif., Feb. 16, 2021 /PRNewswire/ -- TriNet Group, Inc. (NYSE: TNET), a leading provider of comprehensive human resources solutions for small and medium-size businesses, today announced financial results for the fourth quarter and fiscal year ended December 31, 2020. The fourth quarter and fiscal year highlights below include non-GAAP financial measures which are reconciled later in this release.